会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Novel acetylenic prostaglandin analogs
    • 新型炔类前列腺素类似物
    • US4073934A
    • 1978-02-14
    • US677861
    • 1976-04-16
    • Werner SkuballaBernd RaduechelHelmut VorbrueggenWalter ElgerOlaf LogeEckehard Schillinger
    • Werner SkuballaBernd RaduechelHelmut VorbrueggenWalter ElgerOlaf LogeEckehard Schillinger
    • A61K31/23C07C67/00C07C401/00C07C405/00C07D213/30C07D213/55C07D307/38C07D307/54C07D307/935C07D333/06C07C177/00A61K31/19A61K31/215
    • C07D307/935C07C405/00
    • Optically active and racemic prostaglandin derivatives of the formula ##STR1## wherein R.sub.1 is --OR.sub.5 ; --NHSO.sub.2 CH.sub.3 ; or --O--CH.sub.2 --U--V; R.sub.5 is hydrogen, alkyl, aryl, or a heterocyclic group; U is a direct bond, carbonyl or carbonyloxy; and V is phenyl substituted by 1-3 phenyl, alkoxy of 1-2 carbon atoms, or halogen, preferably bromine;R.sub.2 is hydrogen or alkyl of 1-5 carbon atoms;R.sub.3 is alkyl, substituted or unsubstituted cycloalkyl, straight-chain or branched alkyl of 1-5 carbon atoms substituted by aryl or substituted aryl, when R.sub.1 is as above; or R.sub.3 is aryl or substituted aryl group when R.sub.1 is --OR.sub.5 ', --NHSO.sub.2 CH.sub.3, or --O--CH.sub.2 --U--V and R.sub.5 ' is aryl or a heterocyclic group and U and V are as above;R.sub.4 is hydrogen or an ether or acyl residue;A is --CH.sub.2 --CH.sub.2 -- or cis--CH.dbd.CH--;B is --CH.sub.2 --CH.sub.2 -- or trans--CH.dbd.CH--;D is a direct bond, oxygen, or sulfur;Z is carbonyl or >CH OR.sub.4 wherein OR.sub.4 is in the .alpha.- or .beta.-position; andX y is ##STR2## when Z is >CH OR.sub.4 --, or ##STR3## or --CH.dbd.CH-- when Z is carbonyl; AND, WHEN R.sub.1 is hydroxy, the physiologically compatible salts thereof with bases, have more prolonged activity than naturally-occurring prostaglandins.
    • 式(Ⅰ)的光学活性和外消旋前列腺素衍生物,其中R1为-OR5; -NHSO 2 CH 3; 或-O-CH 2 -U-V; R5是氢,烷基,芳基或杂环基; U是直接键,羰基或羰氧基; 并且V是被1-3个苯基,1-2个碳原子的烷氧基或卤素,优选溴取代的苯基; R2是氢或1-5个碳原子的烷基; R 3为烷基,取代或未取代的环烷基,被芳基或取代芳基取代的1-5个碳原子的直链或支链烷基,当R 1如上所述时; 或当R 1为-OR 5',-NHSO 2 CH 3或-O-CH 2 -U-V且R 5'为芳基或杂环基时,R 3为芳基或取代的芳基,U和V如上所述; R4是氢或醚或酰基残基; A是-CH 2 -CH 2 - 或顺式-CH = CH-; B是-CH 2 -CH 2 - 或反式-CH = CH-; D是直接键合,氧或硫; Z是羰基或> CH OR 4,其中OR 4在α或β-位; 当Z为羰基时Z为> CH OR4-或或-CH = CH-时,X Y为 当R1是羟基时,其与碱的生理上相容的盐比天然存在的前列腺素具有更长的活性。